SUBSCRIBE
SUBSCRIBE

Opus Genetics

NEWS
Business
Spark Founders Launch Opus Genetics to Tackle Rare Forms of Blindness
The startup’s initial focus will be on rare blindness conditions affecting pediatric patients.
September 22, 2021
 · 
2 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Press Releases
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - September 12, 2025
September 15, 2025
 · 
2 min read
Press Releases
Opus Genetics Doses First Patient in Pivotal LYNX-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions
September 5, 2025
 · 
6 min read
Press Releases
Opus Genetics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
September 4, 2025
 · 
1 min read
Press Releases
Opus Genetics Appoints Rob Gagnon as Chief Financial Officer
September 3, 2025
 · 
4 min read
Press Releases
Opus Genetics Inherited Retinal Disease Programs Featured at Medical and Industry Conferences in September 2025
August 28, 2025
 · 
2 min read
Press Releases
Opus Genetics Announces FDA Clearance of IND Application for Gene Therapy Candidate OPGx-BEST1
August 19, 2025
 · 
4 min read
Press Releases
Opus Genetics Announces Financial Results for Second Quarter 2025 and Provides Corporate Update
August 14, 2025
 · 
11 min read
Press Releases
Opus Genetics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
August 6, 2025
 · 
1 min read
Press Releases
Opus Genetics and the Global RDH12 Alliance Partner to Advance RDH12 Gene Therapy for Inherited Childhood Blindness
July 24, 2025
 · 
6 min read
Press Releases
Opus Genetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 3, 2025
July 4, 2025
 · 
2 min read
Load More